Interactive Brokers shares jump as it secures spot in S&P 500
BRANFORD, Conn.—John S. Vieceli, the Chief Product Officer of Quantum-Si Inc. (NASDAQ:QSI), recently sold a portion of his holdings in the company, according to a filing with the Securities and Exchange Commission. The transaction, dated March 21, involved the sale of 4,317 shares of Class A common stock, generating a total of $5,981. The shares were sold at a weighted average price of $1.3855, with individual sale prices ranging from $1.36 to $1.405 per share. The sale comes as QSI’s stock has shown significant volatility, with a 55% gain over the past six months despite a 46% decline year-to-date.
The sale was conducted under a mandatory sell-to-cover provision to meet tax withholding obligations related to the vesting of previously granted restricted stock units. Following this transaction, Vieceli retains direct ownership of 864,509 shares of Quantum-Si. The company, with a market capitalization of $271.6 million, maintains a strong liquidity position with more cash than debt on its balance sheet, according to InvestingPro data.
Quantum-Si, headquartered in Branford, Connecticut, is known for its work in the field of measuring and controlling devices. The company continues to develop and innovate in the industrial applications and services sector. With its next earnings report due on May 8, analysts project continued sales growth despite current unprofitability. For deeper insights into QSI’s financial health and growth prospects, investors can access comprehensive analysis through InvestingPro’s detailed research reports.
In other recent news, QuantumSi Inc. reported its fourth-quarter 2024 earnings, which showed a wider-than-expected loss per share and lower-than-anticipated revenue. The company posted an actual EPS of -$0.23, missing the forecast of -$0.19, and reported revenue of $1.2 million, below the expected $1.79 million. Despite the earnings miss, QuantumSi demonstrated significant revenue growth in Q4 2024, with a 52% increase from the previous quarter. For the full year, the company saw a 183% rise in revenue compared to 2023, highlighting its expanding market presence. In January 2025, QuantumSi launched a new product, Platinum Pro, with plans to launch the Proteus platform in the second half of 2026. The company also entered a distribution agreement with Avantor (NYSE:AVTR) for the North American market, expected to significantly increase the number of sales professionals engaged in selling its products. Analysts from Canaccord Genuity and H.C. Wainwright have shown interest in QuantumSi’s recent developments, particularly regarding the impact of the Platinum Pro launch and the Avantor partnership. QuantumSi’s CEO, Jeff Hawkins (NASDAQ:HWKN), emphasized the company’s focus on strategic partnerships and R&D initiatives to unlock potential in the proteomics market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.